Lalomia Brent's most recent trade in Conmed Corp. was a trade of 75 RSUs (Restricted Stock Units) done . Disclosure was reported to the exchange on March 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 75 | 75 | - | - | RSUs (Restricted Stock Units) | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 75 | 1,032 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.73 per share. | 07 Mar 2025 | 26 | 1,006 (0%) | 0% | 62.7 | 1,631 | Common Stock |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 26,895 | 26,895 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brent Lalomia | Executive VP RA, QA | Other type of transaction at price $ 71.55 per share. | 31 Dec 2024 | 22 | 93 | - | 71.5 | 1,574 | 401 (K) Plan |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 75 | 150 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 75 | 983 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.00 per share. | 07 Mar 2024 | 26 | 957 (0%) | 0% | 85 | 2,210 | Common Stock |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 18,988 | 18,988 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Lalomia Brent | Vice President QA and RA | Other type of transaction at price $ 111.00 per share. | 31 Dec 2023 | 18 | 70 | - | 111 | 1,998 | 401 (K) Plan |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2023 | 250 | 979 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2023 | 250 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.63 per share. | 17 Jun 2023 | 71 | 908 (0%) | 0% | 135.6 | 9,630 | Common Stock |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 75 | 225 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 75 | 755 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.31 per share. | 07 Mar 2023 | 26 | 729 (0%) | 0% | 95.3 | 2,478 | Common Stock |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 12,317 | 12,317 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | 31 Dec 2022 | 1 | 680 (0%) | 0% | 108 | 108 | Common Stock | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 250 | 250 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 250 | 750 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brent Lalomia | Vice President QA and RA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.93 per share. | 17 Jun 2022 | 72 | 678 (0%) | 0% | 88.9 | 6,403 | Common Stock |